SEC Form 4 · accession 0001445064-15-000105
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J. Romano
Officer — Sr. VP & Chief Scientific Ofcr
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 1, 2015 | A | 3,326 | $0.00 | A | 3,326 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $120.27 | Jul 1, 2015 | A | 11,275 | A | Jul 1, 2016 | Jul 1, 2025 | Ordinary Shares | 11,275 | 11,275 | D |
Explanation of responses
- F1Represents restricted stock units that vest in four equal installments beginning July 1, 2016.
- F2The options vest in four equal annual installments beginning July 1, 2016.